CFTR-France

Variant details:
Name	NM_000492.4:c.1680-883A>G
Protein name	NP_000483.3:p.(=)
Genomic name (hg19)	chr7:g.117229524A>G UCSC
Genomic name (hg38)	chr7:g.117589470A>G UCSC
#Exon/intron	intron 12
Class	disease-causing
Subclass	CF-causing
WT sequence	GAGAATCCTATGTACTTGAGATATA A GTAAGGTTACTATCAATCACACCTG
Mutant sequence	GAGAATCCTATGTACTTGAGATATA G GTAAGGTTACTATCAATCACACCTG

Other databases:
Not found	Not found	dbSNP rs1554388867

Pathogenicity predictors:
Not found


Reference	PMID	Splicing	mRNA level	Maturation	Localization	Channel fonction (Cl-)	Bicarbonate
Bergougnoux et al, 2018	30389601	✓

« ✓ » indicates the type of analysis performed and not the results

3 individuals carrying this variant are reported in CFTR-NGS catalogue

3 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS	3
CF	3

Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing

Detailed genotypes:
Phenotype	Patient ID	Variant status	Additional variants
CF	152	heterozygote	CF-causing - Trans
CF	173	heterozygote	CF-causing- Undef
CF	1004	heterozygote	CF-causing - Trans

Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing

CFTR variants are clustered into five groups (click here for more details about the classification of variants):

CF-causing: when in trans with another CF-causing mutation, will result in CF.
CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
VUS (Variant of unknown clinical significance): unclassified because of insufficient data.

Go to